Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...
Madrigal Pharmaceuticals has been given Food and Drug Administration market clearance for its experimental treatment for NASH ...